Share Price and Basic Stock Data
Last Updated: February 11, 2026, 10:09 pm
| PEG Ratio | 0.60 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Danlaw Technologies India Ltd operates in the IT Consulting and Software industry, showcasing a robust revenue trajectory. For the fiscal year ending March 2025, the company reported revenues of ₹218 Cr, an increase from ₹167 Cr in the previous year, demonstrating a consistent growth trend. The trailing twelve months (TTM) revenue stood at ₹237 Cr, indicating a healthy upward momentum. Quarterly sales figures reflect this trend, with revenues rising from ₹37.99 Cr in September 2022 to ₹50.05 Cr in September 2023. The most recent quarterly results for December 2023 reported sales of ₹53.02 Cr, further solidifying the company’s growth narrative. The compound annual growth rate (CAGR) for sales from March 2022 to March 2025 is substantial, evidencing a strong market position and increasing demand for its services. This growth is indicative of effective strategic planning and operational efficiency, positioning Danlaw Technologies favorably in a competitive landscape.
Profitability and Efficiency Metrics
Danlaw Technologies has demonstrated commendable profitability metrics, as evidenced by its operating profit margin (OPM), which stood at 14.62%. This is a significant improvement compared to previous years, reflecting the company’s ability to manage costs effectively while enhancing revenue generation. The net profit for the year ending March 2025 was recorded at ₹19 Cr, showcasing a strong return on equity (ROE) of 28.3% and return on capital employed (ROCE) of 28%. Such figures indicate that the company is generating substantial returns for its shareholders, which is particularly impressive in the IT consulting sector. Furthermore, the interest coverage ratio (ICR) of 6.52x suggests that Danlaw comfortably meets its interest obligations, enhancing its financial stability. However, the cash conversion cycle (CCC) of 113 days indicates a potential area for improvement in working capital management, as it suggests a delay in converting sales into cash, which can impact liquidity.
Balance Sheet Strength and Financial Ratios
The balance sheet of Danlaw Technologies reflects a solid financial foundation with total assets amounting to ₹156 Cr as of March 2025. The company has reported reserves of ₹72 Cr, which signifies a strong retained earnings position. However, borrowings stood at ₹35 Cr, indicating a reliance on debt, albeit at a manageable level given the interest coverage ratio. The price-to-book value (P/BV) ratio of 2.70x suggests the stock is trading at a premium relative to its book value, which could reflect investor confidence in the company’s growth prospects. Additionally, the total debt-to-equity ratio of 0.47x indicates a conservative leverage stance, which is favorable in comparison to industry norms. The liquidity ratios present a mixed picture, with a current ratio of 1.81x indicating adequate short-term financial health, yet the quick ratio of 0.88x suggests potential challenges in meeting immediate obligations without liquidating inventory.
Shareholding Pattern and Investor Confidence
Danlaw Technologies has a diverse shareholding structure, with promoters holding 61.87% of the equity as of September 2023, reflecting strong insider confidence in the company’s future. The public holds 37.23% of shares, while foreign institutional investors (FIIs) have maintained a negligible presence, standing at 0.00%. This indicates a potential opportunity for increased foreign interest, which could bolster stock liquidity and investor sentiment if achieved. The number of shareholders increased from 3,584 in December 2022 to 8,756 by September 2025, suggesting growing interest and confidence among retail investors. However, the absence of significant institutional investment could be a risk factor, potentially limiting stock price appreciation and market recognition. The stable promoter holding coupled with increasing public interest may serve as a foundation for future capital raising efforts and strategic initiatives.
Outlook, Risks, and Final Insight
Looking ahead, Danlaw Technologies is poised for continued growth, driven by its strong revenue trends and profitability metrics. However, risks remain, including its reliance on a relatively small domestic market and the challenges posed by a competitive IT landscape. The company’s cash conversion cycle and working capital management need attention to ensure liquidity is maintained. If Danlaw can enhance cash flow management while sustaining its growth trajectory, it could unlock further value for shareholders. Additionally, increasing foreign institutional investment could enhance market perception and liquidity. Conversely, failure to manage debt levels or operational inefficiencies could hinder growth. Overall, Danlaw Technologies presents a compelling investment case, provided it navigates these challenges effectively and capitalizes on its growth potential in the evolving IT consulting sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 44.6 Cr. | 14.1 | 21.0/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 121 Cr. | 112 | 194/99.8 | 18.5 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 46.6 Cr. | 364 | 446/140 | 29.1 | 26.7 | 0.27 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 11.5 Cr. | 2.14 | 2.34/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 19,252.11 Cr | 512.68 | 74.05 | 122.56 | 0.63% | 14.90% | 21.00% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 37.99 | 43.55 | 48.25 | 46.39 | 50.05 | 53.02 | 61.52 | 47.30 | 54.58 | 54.69 | 62.31 | 54.77 | 65.58 |
| Expenses | 34.56 | 37.79 | 39.82 | 39.74 | 40.81 | 43.27 | 50.90 | 41.38 | 47.00 | 46.93 | 51.77 | 47.83 | 55.99 |
| Operating Profit | 3.43 | 5.76 | 8.43 | 6.65 | 9.24 | 9.75 | 10.62 | 5.92 | 7.58 | 7.76 | 10.54 | 6.94 | 9.59 |
| OPM % | 9.03% | 13.23% | 17.47% | 14.33% | 18.46% | 18.39% | 17.26% | 12.52% | 13.89% | 14.19% | 16.92% | 12.67% | 14.62% |
| Other Income | 0.27 | 0.02 | 0.07 | 0.09 | 0.03 | 0.03 | 0.13 | 0.22 | 0.27 | 0.23 | 0.25 | 0.29 | 0.23 |
| Interest | 0.80 | 0.91 | 0.88 | 0.61 | 0.63 | 0.63 | 0.59 | 0.54 | 0.62 | 0.57 | 0.54 | 0.52 | 0.50 |
| Depreciation | 1.13 | 1.20 | 3.74 | 1.22 | 0.92 | 0.93 | 0.93 | 0.94 | 1.33 | 1.40 | 1.44 | 2.02 | 1.93 |
| Profit before tax | 1.77 | 3.67 | 3.88 | 4.91 | 7.72 | 8.22 | 9.23 | 4.66 | 5.90 | 6.02 | 8.81 | 4.69 | 7.39 |
| Tax % | 29.94% | 24.80% | 38.66% | 25.46% | 23.32% | 26.76% | 28.17% | 25.75% | 23.39% | 26.74% | 25.99% | 25.80% | 25.58% |
| Net Profit | 1.24 | 2.76 | 2.38 | 3.66 | 5.92 | 6.03 | 6.62 | 3.47 | 4.52 | 4.41 | 6.52 | 3.47 | 5.50 |
| EPS in Rs | 3.34 | 5.67 | 4.89 | 7.51 | 12.15 | 12.38 | 13.59 | 7.12 | 9.28 | 9.05 | 13.39 | 7.12 | 11.29 |
Last Updated: December 27, 2025, 9:34 am
Below is a detailed analysis of the quarterly data for Danlaw Technologies India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 65.58 Cr.. The value appears strong and on an upward trend. It has increased from 54.77 Cr. (Jun 2025) to 65.58 Cr., marking an increase of 10.81 Cr..
- For Expenses, as of Sep 2025, the value is 55.99 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 47.83 Cr. (Jun 2025) to 55.99 Cr., marking an increase of 8.16 Cr..
- For Operating Profit, as of Sep 2025, the value is 9.59 Cr.. The value appears strong and on an upward trend. It has increased from 6.94 Cr. (Jun 2025) to 9.59 Cr., marking an increase of 2.65 Cr..
- For OPM %, as of Sep 2025, the value is 14.62%. The value appears strong and on an upward trend. It has increased from 12.67% (Jun 2025) to 14.62%, marking an increase of 1.95%.
- For Other Income, as of Sep 2025, the value is 0.23 Cr.. The value appears to be declining and may need further review. It has decreased from 0.29 Cr. (Jun 2025) to 0.23 Cr., marking a decrease of 0.06 Cr..
- For Interest, as of Sep 2025, the value is 0.50 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.52 Cr. (Jun 2025) to 0.50 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 1.93 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.02 Cr. (Jun 2025) to 1.93 Cr., marking a decrease of 0.09 Cr..
- For Profit before tax, as of Sep 2025, the value is 7.39 Cr.. The value appears strong and on an upward trend. It has increased from 4.69 Cr. (Jun 2025) to 7.39 Cr., marking an increase of 2.70 Cr..
- For Tax %, as of Sep 2025, the value is 25.58%. The value appears to be improving (decreasing) as expected. It has decreased from 25.80% (Jun 2025) to 25.58%, marking a decrease of 0.22%.
- For Net Profit, as of Sep 2025, the value is 5.50 Cr.. The value appears strong and on an upward trend. It has increased from 3.47 Cr. (Jun 2025) to 5.50 Cr., marking an increase of 2.03 Cr..
- For EPS in Rs, as of Sep 2025, the value is 11.29. The value appears strong and on an upward trend. It has increased from 7.12 (Jun 2025) to 11.29, marking an increase of 4.17.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:53 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8 | 9 | 11 | 11 | 18 | 26 | 15 | 28 | 122 | 167 | 211 | 218 | 237 |
| Expenses | 9 | 8 | 9 | 11 | 17 | 26 | 19 | 30 | 115 | 147 | 174 | 186 | 203 |
| Operating Profit | -0 | 0 | 2 | 1 | 1 | 0 | -3 | -2 | 6 | 20 | 36 | 32 | 35 |
| OPM % | -5% | 3% | 15% | 6% | 6% | 0% | -21% | -9% | 5% | 12% | 17% | 15% | 15% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 1 | 0 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 3 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 4 | 7 | 4 | 5 | 7 |
| Profit before tax | 1 | 1 | 3 | 2 | 2 | 0 | -4 | -4 | 5 | 10 | 30 | 25 | 27 |
| Tax % | 35% | 20% | 32% | 222% | 30% | 29% | -24% | -27% | 14% | 31% | 26% | 26% | |
| Net Profit | 0 | 1 | 2 | -2 | 1 | 0 | -3 | -3 | 4 | 7 | 22 | 19 | 20 |
| EPS in Rs | 1.08 | 2.53 | 5.11 | -5.27 | 3.02 | 0.84 | -8.82 | -7.26 | 11.54 | 14.88 | 45.64 | 38.84 | 40.85 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | -200.00% | 150.00% | -100.00% | 0.00% | 233.33% | 75.00% | 214.29% | -13.64% |
| Change in YoY Net Profit Growth (%) | 0.00% | -300.00% | 350.00% | -250.00% | 100.00% | 233.33% | -158.33% | 139.29% | -227.92% |
Danlaw Technologies India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 70% |
| 3 Years: | 22% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 51% |
| 3 Years: | 122% |
| TTM: | -14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 71% |
| 3 Years: | 61% |
| 1 Year: | -46% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 25% |
| 3 Years: | 33% |
| Last Year: | 28% |
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: January 7, 2026, 5:17 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 19 | 19 | 21 | 19 | 20 | 20 | 17 | 15 | 23 | 31 | 53 | 72 | 81 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 31 | 38 | 30 | 35 | 32 |
| Other Liabilities | 0 | 1 | 1 | 1 | 5 | 10 | 16 | 15 | 31 | 36 | 45 | 44 | 43 |
| Total Liabilities | 23 | 24 | 26 | 24 | 29 | 35 | 39 | 34 | 90 | 110 | 133 | 156 | 160 |
| Fixed Assets | 1 | 1 | 1 | 1 | 1 | 1 | 8 | 7 | 30 | 34 | 24 | 26 | 42 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 |
| Investments | 3 | 3 | 3 | 3 | 3 | 16 | 16 | 16 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 18 | 20 | 22 | 20 | 25 | 18 | 16 | 11 | 61 | 76 | 109 | 126 | 117 |
| Total Assets | 23 | 24 | 26 | 24 | 29 | 35 | 39 | 34 | 90 | 110 | 133 | 156 | 160 |
Below is a detailed analysis of the balance sheet data for Danlaw Technologies India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Reserves, as of Sep 2025, the value is 81.00 Cr.. The value appears strong and on an upward trend. It has increased from 72.00 Cr. (Mar 2025) to 81.00 Cr., marking an increase of 9.00 Cr..
- For Borrowings, as of Sep 2025, the value is 32.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 35.00 Cr. (Mar 2025) to 32.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 43.00 Cr.. The value appears to be improving (decreasing). It has decreased from 44.00 Cr. (Mar 2025) to 43.00 Cr., marking a decrease of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 160.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 156.00 Cr. (Mar 2025) to 160.00 Cr., marking an increase of 4.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 16.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 5.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 117.00 Cr.. The value appears to be declining and may need further review. It has decreased from 126.00 Cr. (Mar 2025) to 117.00 Cr., marking a decrease of 9.00 Cr..
- For Total Assets, as of Sep 2025, the value is 160.00 Cr.. The value appears strong and on an upward trend. It has increased from 156.00 Cr. (Mar 2025) to 160.00 Cr., marking an increase of 4.00 Cr..
Notably, the Reserves (81.00 Cr.) exceed the Borrowings (32.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | 0.00 | 2.00 | 1.00 | 1.00 | 0.00 | -5.00 | -3.00 | -25.00 | -18.00 | 6.00 | -3.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 71 | 71 | 170 | 275 | 87 | 88 | 47 | 55 | 66 | 60 | 82 |
| Inventory Days | 110 | 188 | 123 | 97 | 97 | 54 | 44 | 22 | 130 | 116 | 117 | 105 |
| Days Payable | 10 | 70 | 68 | 22 | 220 | 178 | 196 | 70 | 68 | 64 | 65 | 74 |
| Cash Conversion Cycle | 138 | 190 | 127 | 245 | 152 | -36 | -65 | -1 | 117 | 118 | 111 | 113 |
| Working Capital Days | 72 | 96 | 81 | 181 | 221 | 28 | -170 | -128 | 62 | 69 | 61 | 60 |
| ROCE % | 3% | 5% | 12% | 7% | 7% | 2% | -17% | -16% | 8% | 21% | 40% | 28% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 11.07 | 0.84 | -12.23 | -1.31 | 3.87 |
| Diluted EPS (Rs.) | 11.07 | 0.84 | -12.23 | -1.31 | 3.86 |
| Cash EPS (Rs.) | 22.31 | 14.93 | -5.39 | 0.56 | 4.38 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 77.06 | 74.64 | 71.67 | 84.07 | 70.37 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 77.06 | 74.64 | 71.67 | 84.07 | 70.37 |
| Revenue From Operations / Share (Rs.) | 327.93 | 266.70 | 147.94 | 147.98 | 52.81 |
| PBDIT / Share (Rs.) | 28.59 | 20.23 | -8.15 | 0.01 | 5.93 |
| PBIT / Share (Rs.) | 17.50 | 9.60 | -16.79 | -3.02 | 5.43 |
| PBT / Share (Rs.) | 13.12 | 7.18 | -17.97 | -3.08 | 5.41 |
| Net Profit / Share (Rs.) | 11.22 | 4.31 | -14.04 | -2.46 | 3.87 |
| NP After MI And SOA / Share (Rs.) | 11.07 | 0.83 | -12.23 | -1.31 | 3.87 |
| PBDIT Margin (%) | 8.71 | 7.58 | -5.50 | 0.00 | 11.23 |
| PBIT Margin (%) | 5.33 | 3.60 | -11.35 | -2.04 | 10.27 |
| PBT Margin (%) | 4.00 | 2.69 | -12.14 | -2.07 | 10.24 |
| Net Profit Margin (%) | 3.42 | 1.61 | -9.48 | -1.66 | 7.33 |
| NP After MI And SOA Margin (%) | 3.37 | 0.31 | -8.26 | -0.88 | 7.33 |
| Return on Networth / Equity (%) | 17.94 | 1.40 | -20.41 | -1.86 | 5.50 |
| Return on Capital Employeed (%) | 11.19 | 7.66 | -16.92 | -3.16 | 7.71 |
| Return On Assets (%) | 4.62 | 0.38 | -6.78 | -0.86 | 4.58 |
| Long Term Debt / Equity (X) | 0.18 | 0.08 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.47 | 0.30 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.91 | 0.55 | 0.32 | 0.78 | 0.66 |
| Current Ratio (X) | 1.81 | 1.39 | 1.25 | 1.92 | 5.70 |
| Quick Ratio (X) | 0.88 | 0.95 | 0.89 | 1.44 | 5.35 |
| Inventory Turnover Ratio (X) | 4.65 | 3.08 | 1.09 | 7.00 | 5.37 |
| Interest Coverage Ratio (X) | 6.52 | 8.35 | -6.92 | 0.09 | 350.15 |
| Interest Coverage Ratio (Post Tax) (X) | 3.56 | 2.78 | -10.91 | -43.07 | 229.58 |
| Enterprise Value (Cr.) | 74.29 | 110.42 | 8.44 | 32.43 | 17.12 |
| EV / Net Operating Revenue (X) | 0.61 | 1.12 | 0.15 | 0.59 | 0.87 |
| EV / EBITDA (X) | 7.01 | 14.72 | -2.79 | 16299.71 | 7.78 |
| MarketCap / Net Operating Revenue (X) | 0.50 | 1.02 | 0.17 | 0.62 | 1.33 |
| Price / BV (X) | 2.70 | 4.59 | 0.43 | 1.31 | 0.99 |
| Price / Net Operating Revenue (X) | 0.50 | 1.02 | 0.17 | 0.62 | 1.33 |
| EarningsYield | 0.06 | 0.00 | -0.47 | -0.01 | 0.05 |
After reviewing the key financial ratios for Danlaw Technologies India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 22, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 21) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 22, the value is 11.07. This value is within the healthy range. It has increased from 0.84 (Mar 21) to 11.07, marking an increase of 10.23.
- For Diluted EPS (Rs.), as of Mar 22, the value is 11.07. This value is within the healthy range. It has increased from 0.84 (Mar 21) to 11.07, marking an increase of 10.23.
- For Cash EPS (Rs.), as of Mar 22, the value is 22.31. This value is within the healthy range. It has increased from 14.93 (Mar 21) to 22.31, marking an increase of 7.38.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 77.06. It has increased from 74.64 (Mar 21) to 77.06, marking an increase of 2.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 77.06. It has increased from 74.64 (Mar 21) to 77.06, marking an increase of 2.42.
- For Revenue From Operations / Share (Rs.), as of Mar 22, the value is 327.93. It has increased from 266.70 (Mar 21) to 327.93, marking an increase of 61.23.
- For PBDIT / Share (Rs.), as of Mar 22, the value is 28.59. This value is within the healthy range. It has increased from 20.23 (Mar 21) to 28.59, marking an increase of 8.36.
- For PBIT / Share (Rs.), as of Mar 22, the value is 17.50. This value is within the healthy range. It has increased from 9.60 (Mar 21) to 17.50, marking an increase of 7.90.
- For PBT / Share (Rs.), as of Mar 22, the value is 13.12. This value is within the healthy range. It has increased from 7.18 (Mar 21) to 13.12, marking an increase of 5.94.
- For Net Profit / Share (Rs.), as of Mar 22, the value is 11.22. This value is within the healthy range. It has increased from 4.31 (Mar 21) to 11.22, marking an increase of 6.91.
- For NP After MI And SOA / Share (Rs.), as of Mar 22, the value is 11.07. This value is within the healthy range. It has increased from 0.83 (Mar 21) to 11.07, marking an increase of 10.24.
- For PBDIT Margin (%), as of Mar 22, the value is 8.71. This value is below the healthy minimum of 10. It has increased from 7.58 (Mar 21) to 8.71, marking an increase of 1.13.
- For PBIT Margin (%), as of Mar 22, the value is 5.33. This value is below the healthy minimum of 10. It has increased from 3.60 (Mar 21) to 5.33, marking an increase of 1.73.
- For PBT Margin (%), as of Mar 22, the value is 4.00. This value is below the healthy minimum of 10. It has increased from 2.69 (Mar 21) to 4.00, marking an increase of 1.31.
- For Net Profit Margin (%), as of Mar 22, the value is 3.42. This value is below the healthy minimum of 5. It has increased from 1.61 (Mar 21) to 3.42, marking an increase of 1.81.
- For NP After MI And SOA Margin (%), as of Mar 22, the value is 3.37. This value is below the healthy minimum of 8. It has increased from 0.31 (Mar 21) to 3.37, marking an increase of 3.06.
- For Return on Networth / Equity (%), as of Mar 22, the value is 17.94. This value is within the healthy range. It has increased from 1.40 (Mar 21) to 17.94, marking an increase of 16.54.
- For Return on Capital Employeed (%), as of Mar 22, the value is 11.19. This value is within the healthy range. It has increased from 7.66 (Mar 21) to 11.19, marking an increase of 3.53.
- For Return On Assets (%), as of Mar 22, the value is 4.62. This value is below the healthy minimum of 5. It has increased from 0.38 (Mar 21) to 4.62, marking an increase of 4.24.
- For Long Term Debt / Equity (X), as of Mar 22, the value is 0.18. This value is below the healthy minimum of 0.2. It has increased from 0.08 (Mar 21) to 0.18, marking an increase of 0.10.
- For Total Debt / Equity (X), as of Mar 22, the value is 0.47. This value is within the healthy range. It has increased from 0.30 (Mar 21) to 0.47, marking an increase of 0.17.
- For Asset Turnover Ratio (%), as of Mar 22, the value is 0.91. It has increased from 0.55 (Mar 21) to 0.91, marking an increase of 0.36.
- For Current Ratio (X), as of Mar 22, the value is 1.81. This value is within the healthy range. It has increased from 1.39 (Mar 21) to 1.81, marking an increase of 0.42.
- For Quick Ratio (X), as of Mar 22, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 0.95 (Mar 21) to 0.88, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 22, the value is 4.65. This value is within the healthy range. It has increased from 3.08 (Mar 21) to 4.65, marking an increase of 1.57.
- For Interest Coverage Ratio (X), as of Mar 22, the value is 6.52. This value is within the healthy range. It has decreased from 8.35 (Mar 21) to 6.52, marking a decrease of 1.83.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 22, the value is 3.56. This value is within the healthy range. It has increased from 2.78 (Mar 21) to 3.56, marking an increase of 0.78.
- For Enterprise Value (Cr.), as of Mar 22, the value is 74.29. It has decreased from 110.42 (Mar 21) to 74.29, marking a decrease of 36.13.
- For EV / Net Operating Revenue (X), as of Mar 22, the value is 0.61. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 21) to 0.61, marking a decrease of 0.51.
- For EV / EBITDA (X), as of Mar 22, the value is 7.01. This value is within the healthy range. It has decreased from 14.72 (Mar 21) to 7.01, marking a decrease of 7.71.
- For MarketCap / Net Operating Revenue (X), as of Mar 22, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 21) to 0.50, marking a decrease of 0.52.
- For Price / BV (X), as of Mar 22, the value is 2.70. This value is within the healthy range. It has decreased from 4.59 (Mar 21) to 2.70, marking a decrease of 1.89.
- For Price / Net Operating Revenue (X), as of Mar 22, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 21) to 0.50, marking a decrease of 0.52.
- For EarningsYield, as of Mar 22, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 21) to 0.06, marking an increase of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Danlaw Technologies India Ltd:
- Net Profit Margin: 3.42%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.19% (Industry Average ROCE: 14.9%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.94% (Industry Average ROE: 21%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.88
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.2 (Industry average Stock P/E: 74.05)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.47
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.42%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Unit No. 201,202 & 203, Gowra Fountainhead, Hyderabad Telangana 500081 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Raju S Dandu | Chairman & Wholetime Director |
| Mr. Shireesh Shantaram Phal | Executive Director |
| Mr. M A Ashok Kumar | Independent Director |
| Mr. Venigalla Sambasivarao | Independent Director |
| Mr. Indraganty Venkateswara Sarma | Independent Director |
| Mr. Putrevu Seshagiri Rao | Independent Director |
| Mr. Timothy Matthew Morris | Director |
| Ms. M Sridevi | Woman Director |
FAQ
What is the intrinsic value of Danlaw Technologies India Ltd?
Danlaw Technologies India Ltd's intrinsic value (as of 12 February 2026) is ₹900.16 which is 27.50% higher the current market price of ₹706.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹344 Cr. market cap, FY2025-2026 high/low of ₹1,448/675, reserves of ₹81 Cr, and liabilities of ₹160 Cr.
What is the Market Cap of Danlaw Technologies India Ltd?
The Market Cap of Danlaw Technologies India Ltd is 344 Cr..
What is the current Stock Price of Danlaw Technologies India Ltd as on 12 February 2026?
The current stock price of Danlaw Technologies India Ltd as on 12 February 2026 is ₹706.
What is the High / Low of Danlaw Technologies India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Danlaw Technologies India Ltd stocks is ₹1,448/675.
What is the Stock P/E of Danlaw Technologies India Ltd?
The Stock P/E of Danlaw Technologies India Ltd is 17.2.
What is the Book Value of Danlaw Technologies India Ltd?
The Book Value of Danlaw Technologies India Ltd is 176.
What is the Dividend Yield of Danlaw Technologies India Ltd?
The Dividend Yield of Danlaw Technologies India Ltd is 0.00 %.
What is the ROCE of Danlaw Technologies India Ltd?
The ROCE of Danlaw Technologies India Ltd is 28.0 %.
What is the ROE of Danlaw Technologies India Ltd?
The ROE of Danlaw Technologies India Ltd is 28.3 %.
What is the Face Value of Danlaw Technologies India Ltd?
The Face Value of Danlaw Technologies India Ltd is 10.0.